Eqis Capital Management Inc. acquired a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the second quarter, Holdings Channel reports. The institutional investor acquired 8,153 shares of the medical research company’s stock, valued at approximately $484,000.

Other large investors also recently made changes to their positions in the company. Park National Corp OH increased its stake in shares of Agilent Technologies by 1.1% in the second quarter. Park National Corp OH now owns 4,077 shares of the medical research company’s stock worth $242,000 after buying an additional 43 shares during the period. Quadrant Capital Group LLC raised its stake in Agilent Technologies by 0.9% in the first quarter. Quadrant Capital Group LLC now owns 5,470 shares of the medical research company’s stock worth $284,000 after buying an additional 50 shares during the last quarter. Trust Co. of Vermont raised its stake in Agilent Technologies by 1.8% in the second quarter. Trust Co. of Vermont now owns 2,793 shares of the medical research company’s stock worth $166,000 after buying an additional 50 shares during the last quarter. Cribstone Capital Management LLC raised its stake in Agilent Technologies by 2.3% in the first quarter. Cribstone Capital Management LLC now owns 2,359 shares of the medical research company’s stock worth $125,000 after buying an additional 54 shares during the last quarter. Finally, Neuberger Berman Group LLC raised its stake in Agilent Technologies by 0.9% in the first quarter. Neuberger Berman Group LLC now owns 9,840 shares of the medical research company’s stock worth $520,000 after buying an additional 91 shares during the last quarter.

Agilent Technologies, Inc. (NYSE:A) opened at 61.37 on Friday. The firm has a market capitalization of $19.72 billion, a P/E ratio of 34.50 and a beta of 1.30. Agilent Technologies, Inc. has a 1-year low of $42.92 and a 1-year high of $61.84. The stock has a 50 day moving average of $60.03 and a 200-day moving average of $54.38.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Monday, May 22nd. The medical research company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.48 by $0.10. The business had revenue of $1.10 billion for the quarter, compared to analysts’ expectations of $1.05 billion. Agilent Technologies had a net margin of 13.41% and a return on equity of 16.49%. The firm’s revenue was up 8.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.44 EPS. On average, equities research analysts anticipate that Agilent Technologies, Inc. will post $2.23 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 26th. Investors of record on Monday, July 3rd will be given a $0.132 dividend. The ex-dividend date is Thursday, June 29th. This represents a $0.53 annualized dividend and a yield of 0.86%. Agilent Technologies’s dividend payout ratio is currently 29.78%.

TRADEMARK VIOLATION WARNING: “Eqis Capital Management Inc. Acquires New Position in Agilent Technologies, Inc. (NYSE:A)” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another publication, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be viewed at https://www.thecerbatgem.com/2017/07/22/eqis-capital-management-inc-acquires-new-position-in-agilent-technologies-inc-nysea.html.

A number of analysts have recently issued reports on A shares. Robert W. Baird increased their target price on Agilent Technologies from $57.00 to $62.00 and gave the company an “outperform” rating in a report on Wednesday, May 24th. Deutsche Bank AG restated a “buy” rating and issued a $58.00 target price (up previously from $56.00) on shares of Agilent Technologies in a report on Sunday, April 2nd. Morgan Stanley increased their target price on Agilent Technologies from $65.00 to $70.00 and gave the company an “overweight” rating in a report on Wednesday, May 24th. Zacks Investment Research upgraded Agilent Technologies from a “hold” rating to a “buy” rating and set a $63.00 target price for the company in a report on Tuesday, May 16th. Finally, BidaskClub lowered Agilent Technologies from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 13th. Two investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $60.12.

In other Agilent Technologies news, insider Patrick Kaltenbach sold 2,000 shares of the business’s stock in a transaction dated Monday, April 24th. The shares were sold at an average price of $54.50, for a total transaction of $109,000.00. Following the sale, the insider now directly owns 42,132 shares of the company’s stock, valued at approximately $2,296,194. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Michael R. Mcmullen sold 50,000 shares of the business’s stock in a transaction dated Tuesday, May 23rd. The stock was sold at an average price of $59.86, for a total transaction of $2,993,000.00. The disclosure for this sale can be found here. Insiders sold a total of 152,119 shares of company stock worth $8,932,719 over the last ninety days.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Stock Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related stocks with our FREE daily email newsletter.